This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ryvu Therapeutics S.a.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Adam Radzimierski: Innovator in Functionalized Heterocyclic Compounds
Introduction
Adam Radzimierski is a notable inventor based in Cracow, Poland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the stimulator of interferon genes (STING). His work is crucial in advancing therapeutic options for various diseases.
Latest Patents
Adam holds a patent for "Functionalized heterocyclic compounds as modulators of stimulator of interferon genes (STING)." This invention relates to compound-linker constructs and antibody-drug-conjugates that are useful as modulators of STING. The patent highlights the potential of these compounds in therapeutic applications.
Career Highlights
Adam is currently employed at Ryvu Therapeutics S.A., a company dedicated to developing innovative therapies for cancer treatment. His role involves extensive research and development, contributing to the company's mission of advancing healthcare solutions.
Collaborations
Adam has collaborated with notable colleagues, including Magdalena Izabela Zawadzka and Luigi Piero Stasi. These partnerships enhance the research environment and foster innovation within the company.
Conclusion
Adam Radzimierski is a prominent figure in the field of medicinal chemistry, with a focus on developing innovative compounds for therapeutic use. His contributions are paving the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile